Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilucoplan in generalized Myasthenia Gravis
NCT03315130Phase 2Completed
- Sponsor
- Ra Pharmaceuticals
- Start
- Oct 2017
- Primary completion
- Dec 2018
- Modality
- Cyclic Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of zilucoplan in myasthenia gravis (MG), sponsored by Ra Pharmaceuticals. Started Oct 2017; status: completed.
02
Drugs
zilucoplan
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT03315130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03315130.